Additional funding of $20 million accelerates commercialization of Trailhead's iPSC-derived human cell and media products.
The funding, part of a new ARPA-H bioprinting initiative, aims to create transplant-ready organs—potentially within ...
A stretch of viral DNA in the mouse genome gives cells in early-stage embryos the potential to become almost any cell type in ...
As we age, we don't recover from injury or illness like we did when we were young. But new research from UCSF has found gene ...
Trailhead Biosystems Inc. ( a biotechnology company advancing human cell innovation, has added $20 million in new funding, expanding the financing announced in May 2025 to $40 million. The funding ...
GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...
Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...
Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced the expansion of its Scientific Advisory ...
Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...
Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...
Lineage Cell Therapeutics (LCTX) announced the receipt of an induced pluripotent stem cell line containing hypoimmunity edits, from Factor ...
It's true that vitamin C can give your immune system a boost, but when it comes to treating or preventing colds, things get a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback